Open AccessSerum Biomarker Status with a Distinctive Pattern in Prognosis of Gastroenteropancreatic Neuroendocrine Carcinoma
Author(s) -
Jianwei Zhang,
Yanshuo Cao,
Panpan Zhang,
Xiaotian Zhang,
Jian Li,
Jun Zhou,
Xicheng Wang,
Zhi Peng,
Yu Sun,
Jie Li,
Lin Shen,
Ming Lu
Publication year - 2021
Publication title -
neuroendocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.493
H-Index - 101
eISSN - 1423-0194
pISSN - 0028-3835
DOI - 10.1159/000519948
Subject(s) - medicine , carcinoembryonic antigen , gastroenterology , hazard ratio , oncology , univariate analysis , adenocarcinoma , biomarker , regimen , population , neuroendocrine tumors , cancer , multivariate analysis , confidence interval , biochemistry , chemistry , environmental health
Gastroenteropancreatic neuroendocrine carcinoma (GEPNEC) is a major research focus, but the application of biomarkers to guide its prognostication and management is unsatisfying. Clinical values of conventional serum biomarkers, neuron-specific enolase (NSE), carcinoembryonic antigen (CEA), and carbohydrate antigen 19-9 (CA199) warrant scrutiny.